Aytu BioPharma Inc.

1.23
-0.01 (-0.81%)
At close: Mar 24, 2025, 3:53 PM
1.23
0.00%
After-hours: Mar 24, 2025, 06:06 PM EDT
-0.81%
Bid 1.23
Market Cap 7.59M
Revenue (ttm) 69.19M
Net Income (ttm) -5.28M
EPS (ttm) -2.08
PE Ratio (ttm) -0.59
Forward PE 3.98
Analyst n/a
Ask 1.34
Volume 14,320
Avg. Volume (20D) 33,986
Open 1.24
Previous Close 1.24
Day's Range 1.21 - 1.25
52-Week Range 1.15 - 3.45
Beta -1.64

About AYTU

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the...

Sector Healthcare
IPO Date Sep 25, 2008
Employees 102
Stock Exchange NASDAQ
Ticker Symbol AYTU
Full Company Profile
1 month ago
-0.72%
Aytu BioPharma shares are trading higher after the... Unlock content with Pro Subscription
4 months ago
-11.43%
Aytu BioPharma shares are trading lower. The company reported Q1 financial results.